BeOne Medicines AG
Status: Publicly traded
Direct answer
BeOne Medicines AG is publicly traded on NASDAQ under the ticker ONC.
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid...
Can you invest in BeOne Medicines AG?
Yes. BeOne Medicines AG trades publicly on NASDAQ as ONC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BeOne Medicines AG
Detailed equity research is provided by MarketSnap.